Siegfried Holding AG

SFZN

Company Profile

  • Business description

    Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.

  • Contact

    Untere Bruehlstrasse 4
    ZofingenCH-4800
    CHE

    T: +41 627461111

    E: [email protected]

    https://www.siegfried.ch

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    3,891

Stocks News & Analysis

stocks

ASX gold miner under pressure to sell by activist investor

Activist investor presses gold miner on selling to larger players.
stocks

Ask the Analyst: Will Amcor lose its dividend aristocrat status?

When consistency becomes constraint.
stocks

Chart of the Week: We see opportunity in this beaten down industrial player

The market sees risks and are discounting the shares excessively.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,916.9058.60-0.65%
CAC 408,244.290.000.00%
DAX 4024,944.95149.010.60%
Dow JONES (US)51,561.93874.861.73%
FTSE 10010,360.3228.020.27%
HKSE25,253.40379.81-1.48%
NASDAQ26,830.9623.02-0.09%
Nikkei 22567,470.69931.45-1.36%
NZX 50 Index13,111.029.410.07%
S&P 5007,584.3130.630.41%
S&P/ASX 2008,686.1059.50-0.68%
SSE Composite Index4,057.7826.19-0.64%

Market Movers